Pfizer has co-led a second funding round for the biotechnology company, which also counts Eli Lilly and GlaxoSmithKline as backers.
US-based biotechnology company Nimbus Therapeutics closed a $43m oversubscribed series B round yesterday co-led by Pfizer’s corporate venturing unit Pfizer Venture Investments and venture capital firm Lightstone Ventures.
Lilly Ventures and SR One, the respective corporate venturing arms of pharmaceutical companies Eli Lilly and GlaxoSmithKline, also took part in the round alongside VC firm Atlas Venture, and Bill Gates, founder of software company Microsoft and co-founder of the Bill and Melinda Gates Foundation.
The company has also changed its name…
